microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma.
暂无分享,去创建一个
Yonghong Xiao | David L Rimm | James J Collins | Simona Colla | Lynda Chin | Sharmistha Sarkar | Cameron Brennan | Benito Campos | Kunal Rai | Lawrence Kwong | Hailei Zhang | Haoqiang Ying | J. Collins | L. Chin | W. Wiedemeyer | Yonghong Xiao | C. Brennan | Hailei Zhang | D. Rimm | S. Colla | G. Genovese | L. Kwong | Chang-Jiun Wu | S. Shukla | Jianhua Zhang | B. Campos | Kunal Rai | Sharmistha Sarkar | Hongwu Zheng | H. Ying | P. Ghosh | K. Dunn | S. Quayle | Ayla Ergun | Jianhua Zhang | J. Hanna | Chang-Jiun Wu | Giannicola Genovese | Sachet A Shukla | Jason Hanna | Hongwu Zheng | Papia Ghosh | Steven N Quayle | Katherine Dunn | Wolf Ruprecht Wiedemeyer | Ayla Ergun | J. Collins | Katherine L. Dunn
[1] Päivi Heikkilä,et al. MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer , 2011, PloS one.
[2] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[3] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[4] Filip Pattyn,et al. The microRNA body map: dissecting microRNA function through integrative genomics , 2011, Nucleic acids research.
[5] R. Einspanier,et al. Integrated MicroRNA-mRNA-Analysis of Human Monocyte Derived Macrophages upon Mycobacterium avium subsp. hominissuis Infection , 2011, PloS one.
[6] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[7] M. Caligiuri,et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Croce. Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.
[10] J. Collins,et al. Large-Scale Mapping and Validation of Escherichia coli Transcriptional Regulation from a Compendium of Expression Profiles , 2007, PLoS biology.
[11] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[12] Seon-Young Kim,et al. PAGE: Parametric Analysis of Gene Set Enrichment , 2005, BMC Bioinform..
[13] S. Berger,et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.
[14] Doron Betel,et al. The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..
[15] Kohei Miyazono,et al. TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.
[16] J. Uhm,et al. The transcriptional network for mesenchymal transformation of brain tumours , 2010 .
[17] H. Hermeking. The miR-34 family in cancer and apoptosis , 2010, Cell Death and Differentiation.
[18] N. Rajewsky,et al. Natural selection on human microRNA binding sites inferred from SNP data , 2006, Nature Genetics.
[19] Yunqing Li,et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. , 2009, Cancer research.
[20] Chris Sander,et al. miR-34a Repression in Proneural Malignant Gliomas Upregulates Expression of Its Target PDGFRA and Promotes Tumorigenesis , 2012, PloS one.
[21] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[22] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[23] R. Verhaak,et al. Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation , 2012, Nature.
[24] Jennifer P Morton,et al. MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma , 2011, Clinical Cancer Research.
[25] Gerald C. Chu,et al. P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation , 2008, Nature.
[26] Xuerui Yang,et al. An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma , 2011, Cell.
[27] Ferdinando Di Cunto,et al. Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs , 2011, Cell.
[28] J. Uhm. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .
[29] P. Pandolfi,et al. In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma , 2011, Cell.
[30] J. Massagué,et al. TGFβ in Cancer , 2008, Cell.
[31] Yong Jin Choi,et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming , 2011, Nature Cell Biology.
[32] J. Uhm. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2009 .
[33] Yanghua Xiao,et al. Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma , 2010, BMC Systems Biology.
[34] J. Baselga,et al. TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.
[35] Manuela Zucknick,et al. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] C. Brennan,et al. Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations , 2009, PloS one.
[37] Y. Pilpel,et al. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC , 2010, Cell Death and Differentiation.
[38] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[39] Luigi Naldini,et al. Stable knockdown of microRNA in vivo by lentiviral vectors , 2009, Nature Methods.
[40] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[41] E. Schadt,et al. Characterizing the role of miRNAs within gene regulatory networks using integrative genomics techniques , 2011, Molecular systems biology.
[42] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[43] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[44] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[45] J. Yates,et al. MicroRNA Regulation of Molecular Networks Mapped by Global MicroRNA, mRNA, and Protein Expression in Activated T Lymphocytes , 2011, The Journal of Immunology.
[46] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[47] W. Filipowicz,et al. The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.
[48] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.